Osaic Holdings
CTOR

Osaic Holdings’s Citius Oncology CTOR Stock Holding History

Osaic Holdings’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.28K Sell
10,125
-1,300
-11% -$1.31K ﹤0.01% 6564
2025
Q4 		$11.4K Sell
11,425
-320
-3% -$459 ﹤0.01% 6260
2025
Q3 		$25.2K Buy
11,745
+6,395
+120% +$13.9K ﹤0.01% 5777
2025
Q2 		$23.3K Buy
5,350
+5,000
+1,429% +$5.84K ﹤0.01% 5594
2025
Q1 		$325 Sell
350
-5,130
-94% -$5.5K ﹤0.01% 7087
2024
Q4 		$6.3K Hold
5,480
– – ﹤0.01% 6065
2024
Q3 		$7.62K Buy
+5,480
New +$38.9K ﹤0.01% 5984

Other funds holding CTOR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings's CTOR Position: Q1 2026 in Review

Osaic Holdings reduced its Citius Oncology (CTOR) stake by 11% in Q1 2026, selling an estimated $1.31K and leaving 10,125 shares worth $6.28K. The position accounts for ﹤0.01% of the portfolio, ranked #6564.

Osaic Holdings first reported a position in CTOR in Q3 2024 and has held it in 7 quarters since. The position peaked at $25.2K in Q3 2025. 14 funds tracked by Wall St. Rank hold CTOR as of Q1 2026.

  • Osaic Holdings held 10,125 shares of Citius Oncology worth $6.28K as of Q1 2026.
  • Osaic Holdings sold 1,300 Citius Oncology shares in Q1 2026, an estimated $1.31K.
  • Citius Oncology made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6564 holding.
  • Osaic Holdings first reported a position in Citius Oncology in Q3 2024 and has held it in 7 quarters since.
  • Osaic Holdings's Citius Oncology position peaked at $25.2K in Q3 2025.
  • 14 funds tracked by Wall St. Rank held Citius Oncology as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.